Leukotriene Receptor Antagonism and the Prevention of Extracellular Matrix Degradation During Atherosclerosis and In-Stent Stenosis | Zendy

Hanna Hlawaty | Zendy; MariePaule Jacob | Zendy; Liliane Louedec | Zendy; Didier Letourneur | Zendy; Charles Brink | Zendy; JeanBaptiste Michel | Zendy; Laurent J. Feldman | Zendy; Magnus Bäck | Zendy

Open Access

Leukotriene Receptor Antagonism and the Prevention of Extracellular Matrix Degradation During Atherosclerosis and In-Stent Stenosis

Author(s) -

Hanna Hlawaty,

MariePaule Jacob,

Liliane Louedec,

Didier Letourneur,

Charles Brink,

JeanBaptiste Michel,

Laurent J. Feldman,

Magnus Bäck

Publication year - 2009

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.108.181750

Subject(s) - medicine , intimal hyperplasia , restenosis , angioplasty , stent , stenosis , neointima , coronary arteries , endocrinology , cardiology , artery , smooth muscle

The lipid-derived inflammatory mediators leukotrienes (LTs) are produced during vascular injury. The aim of the present study was to determine the role of LT receptor signaling in the pathophysiology of in-stent stenosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research